DailyStocks Stock Article Search

https://seekingalpha.com/article/4684357-united-parks-resorts-stock-ebitda-to-see-healthy-growth-in-fy24?source=feed_all_articles Apr 17, 2024 - United Parks & Resorts operates 13 theme parks and is tied to consumer spending power. Learn why I recommend a buy rating for PRKS stock. 0

https://www.cnbc.com/2024/04/17/wall-street-pushes-out-rate-cut-expectations-sees-risk-of-no-action-until-2025.html Apr 17, 2024 - Experts now see the Fed waiting until at least September and are increasingly entertaining the possibility of no cuts at all this year. 0

https://www.cnbc.com/2024/04/16/us-economy-will-see-more-things-break-in-2025-if-rates-stay-high-strategist.html Apr 16, 2024 - Altaf Kassam told CNBC that classic monetary policy mechanisms had "broken." 0

https://www.zacks.com/stock/news/2256071/wall-street-analysts-see-a-95-06-upside-in-sigma-lithium-sgml-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2256071 Apr 16, 2024 - The consensus price target hints at a 95.1% upside potential for SIGMA LITHIUM (SGML). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. 0

https://seekingalpha.com/news/4089749-stifel-upgrades-masimo-to-buy-sees-room-for-share-price-appreciation?source=feed_sector_healthcare Apr 15, 2024 - Stifel upgraded Masimo (MASI) to buy, citing improvement in the company's healthcare business, gross margin expansion, cost reductions and the separation of its consumer business. 0

https://www.cnbc.com/2024/04/15/us-wage-growth-is-cooling-but-its-still-hot-in-these-jobs.html Apr 15, 2024 - The growth in workers' annual earnings has retreated from an initial surge during the Covid-19 pandemic. But some jobs are still paying healthy raises. 0

https://www.zacks.com/stock/news/2255332/wall-street-analysts-see-a-25-23-upside-in-chart-industries-gtls-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2255332 Apr 15, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 25.2% in Chart Industries (GTLS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. 0

https://www.zacks.com/stock/news/2255218/wall-street-analysts-see-crescent-point-cpg-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2255218 Apr 15, 2024 - According to the average brokerage recommendation (ABR), one should invest in Crescent Point (CPG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock? 0

https://seekingalpha.com/news/4089446-needham-sees-bsx-cnmd-rmd-beating-street-despite-medtech-slow-down?source=feed_sector_healthcare Apr 14, 2024 - Needham estimates Q1 medtech sales grew less than expected, but that Boston Scientific, CONMED, ResMed and Surmodics should still be able to beat the Street. Read more here. 0

https://www.fool.com/investing/2024/04/14/half-of-wall-street-covering-analysts-are-calling/?source=iedfolrf0000001 Apr 14, 2024 - There might be a rebound happening even now. 0